Published 6 issues per year
ISSN Print: 1045-4403
ISSN Online: 2162-6502
Indexed in
Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies
ABSTRACT
Notch signaling is a well-conserved cell-fate determining factor in embryo development, and the dyregulation of this signaling is frequently observed in many types of cancers, including hematological malignancies. In this review, we briefly describe the Notch signaling pathway, and we primarily focus on the relationship between Notch and hematological malignancies. We also discuss the clinical development of promising agents including γ-secretase inhibitors (GSIs) and monoclonal antibodies (mAbs). Complete response has been observed among patients with T-cell acute lymphoblastic leukemia (T-ALL) when treated with GSIs. Furthermore, a recent study has suggested that targeting Zmiz1, a direct, selective cofactor of Notch1, rather than targeting Notch directly, maybe helpful to reduce the current target-related toxicities. Taken together, we summarize the role of Notch signaling in hematological malignancies and discuss the treatment strategies for these diseases through targeting Notch signaling.
-
Mrazek Frantisek, Schneiderova Petra, Kriegova Eva, Raida Ludek, Kuba Adam, Gajdos Petr, Königova Nikola, Onderkova Jana, Ambruzova Zuzana, Profile of Inflammation-Associated Proteins in Early Post-Transplant Samples of Patients After Allogeneic Hematopoietic Stem Cell Transplantation: a Preliminary Study, Archivum Immunologiae et Therapiae Experimentalis, 64, S1, 2016. Crossref
-
Evangelisti Camilla, Chiarini Francesca, McCubrey James, Martelli Alberto, Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update, International Journal of Molecular Sciences, 19, 7, 2018. Crossref
-
Shan Huizhuang, Li Xiangyun, Xiao Xinhua, Dai Yuting, Huang Jinyan, Song Junjun, Liu Meng, Yang Li, Lei Hu, Tong Yin, Zhou Li, Xu Hanzhang, Wu Yingli, USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia, Signal Transduction and Targeted Therapy, 3, 1, 2018. Crossref
-
Zhu Bo, Sun Lichun, Luo Wei, Li Min, Coy David H., Yu Long, Yu Wenbo, Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2, Oncotarget, 8, 14, 2017. Crossref